NICHI-IKO PHARMACEUTICAL CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public, Subsidiary
- Established
- 1965-01-01
- Employees
- 2.6K
- Market Cap
- -
- Website
- http://www.nichiiko.co.jp
Clinical Trials
4
Active:0
Completed:4
Trial Phases
2 Phases
Phase 1:2
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Phase 3
2 (50.0%)A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)
- First Posted Date
- 2016-12-13
- Last Posted Date
- 2023-01-30
- Lead Sponsor
- Nichi-Iko Pharmaceutical Co., Ltd.
- Target Recruit Count
- 683
- Registration Number
- NCT02990806
- Locations
- 🇬🇧
Nichi-Iko Investigational Site, Truro, United Kingdom
Pharmacokinetics Study of NI-071
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2013-08-29
- Last Posted Date
- 2014-06-30
- Lead Sponsor
- Nichi-Iko Pharmaceutical Co., Ltd.
- Target Recruit Count
- 96
- Registration Number
- NCT01931189
- Locations
- 🇯🇵
NichiIko Investigational Site, Tokyo, Japan
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis
Phase 3
Completed
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2013-08-22
- Last Posted Date
- 2016-04-08
- Lead Sponsor
- Nichi-Iko Pharmaceutical Co., Ltd.
- Target Recruit Count
- 242
- Registration Number
- NCT01927263
- Locations
- 🇯🇵
NichiIko Investigational Site, Sendai-Shi, Japan
Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis
Phase 1
Completed
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2012-03-30
- Last Posted Date
- 2013-06-19
- Lead Sponsor
- Nichi-Iko Pharmaceutical Co., Ltd.
- Target Recruit Count
- 14
- Registration Number
- NCT01567358
- Locations
- 🇯🇵
392001001, Sendai, Miyagi, Japan
News
No news found